Tuberculosis infection: Insight from immunogenomics

Drug Discovery Today: Disease Mechanisms

Volumn 4, Issue 4, 2007, Pages 231-236

  Arentz, Matthew ^a   Hawn, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; IMMUNOMODULATING AGENT; ISONIAZID; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR 9 AGONIST; TOLL LIKE RECEPTOR AGONIST; TOLL LIKE RECEPTOR ANTAGONIST;

ADAPTIVE IMMUNITY; CELLULAR IMMUNITY; DENDRITIC CELL; DRUG EFFICACY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MACROPHAGE; MORBIDITY; MORTALITY; MYCOBACTERIUM; NONHUMAN; REVIEW; TUBERCULOSIS; VACCINATION;

EID: 47049101400     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2007.11.003     Document Type: Review

References (45)

1. Colditz G.A., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J. Am. Med. Assoc. 271 (1994) 698-702
2. Kaufmann S.H. Tuberculosis: back on the immunologists' agenda. Immunity 24 (2006) 351-357
3. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
4. Berrington W.R., and Hawn T.R. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?. Immunol. Rev. 219 (2007) 167-186
5. Casanova J.L., and Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20 (2002) 581-620
6. Hill A.V. Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet. 40 (2006) 469-486
7. Remus N., et al. Human genetics of common mycobacterial infections. Immunol. Res. 28 (2003) 109-129
8. Akira S., et al. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
9. Beutler B., et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24 (2006) 353-389
10. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 449 (2007) 819-826
11. Heldwein K.A., and Fenton M.J. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4 (2002) 937-944
12. Quesniaux V., et al. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6 (2004) 946-959
13. Rothfuchs A.G., et al. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J. Immunol. 179 (2007) 3463-3471
14. Yadav M., and Schorey J.S. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108 (2006) 3168-3175
15. Comstock G.W. Tuberculosis in twins: a re-analysis of the Prophit survey. Am. Rev. Respir. Dis. 117 (1978) 621-624
16. Greenwood C.M., et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am. J. Hum. Genet. 67 (2000) 405-416
17. Baghdadi J.E., et al. An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults. J. Exp. Med. 203 (2006) 1679-1684
18. Jamieson S.E., et al. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes. Immun. 5 (2004) 46-57
19. Bellamy R., et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8005-8009
20. Fernando S.L., and Britton W.J. Genetic susceptibility to mycobacterial disease in humans. Immunol. Cell Biol. 84 (2006) 125-137
21. Schroder N.W., et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175 (2005) 2534-2540
22. Ogus A.C., et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 23 (2004) 219-223
23. Yim J.J., et al. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes. Immun. 7 (2006) 150-155
24. Thuong N.T., et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes. Immun. 8 (2007) 422-428
25. Hawn T.R., et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur. J. Immunol. 37 (2007) 2280-2289
26. Johnson C.M., et al. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 178 (2007) 7520-7524
27. Khor C.C., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 39 (2007) 523-528
28. Hawn T.R., et al. A polymorphism in toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J. Infect. Dis. 194 (2006) 1127-1134
29. Cooper A.M., et al. Interleukin-12 and tuberculosis: an old story revisited. Curr. Opin. Immunol. 19 (2007) 441-447
30. Khader S.A., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 (2007) 369-377
31. Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199 (2004) 227-250
32. Pulendran B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J. Immunol. 174 (2005) 2457-2465
33. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5 (2006) 471-484
34. Geijtenbeek T.B., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197 (2003) 7-17
35. van Beelen A.J., et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27 (2007) 660-669
36. Cooke G.S., and Hill A.V. Genetics of susceptibility to human infectious disease. Nat. Rev. Genet. 2 (2001) 967-977
37. Barreiro L.B., et al. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med. 3 (2006) e20
38. Sakuntabhai A., et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37 (2005) 507-513
39. Gomez L.M., et al. Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum. Immunol. 67 (2006) 808-811
40. Akahoshi M., et al. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum. Genet. 112 (2003) 237-243
41. Tso H.W., et al. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J. Infect. Dis. 190 (2004) 913-919
42. Lee H.W., et al. Lack of an association between interleukin-12 receptor beta1 polymorphisms and tuberculosis in Koreans. Respiration 72 (2005) 365-368
43. Remus N., et al. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. J. Infect. Dis. 190 (2004) 580-587
44. Pulendran B., and Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124 (2006) 849-863
45. Alderson M.R., et al. TLR4 agonists as immunomodulatory agents. J. Endotoxin. Res. 12 (2006) 313-319